Nassim Usman is the founder of Totus Medicines. Totus Medicines has raised $107M in total funding. Latest round: Series B. Backed by DCVC Bio.
Nassim Usman, Ph.D., was appointed President and Chief Executive Officer of Totus Medicines in December 2023. He leads Totus, a clinical-stage biotech firm focused on covalent small molecule drug discovery using AI and DNA-encoded chemistry, and also serves on the company's Board of Directors. His appointment coincided with the closing of a $66 million Series B financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library